Powered by MOMENTUM MEDIA

JP2060 Phase 3 contender sets sights on human health research

Leidos Australia has signed a memorandum of understanding (MoU) with Monash University to collaborate on research and development at the Monash Institute of Medical Engineering (MIME).

MIME fosters and co-ordinates translational medtech research across Monash University faculties, partner hospitals and collaborating medical research institutions. The clinician-led research programs focus on major clinical and health system needs, and integrate expertise from across engineering, information technology, science, biomedical and clinical research to develop new devices, diagnostics, therapeutics, delivery systems and clinical tools.

Advertisement
Advertisement

 

The MoU, signed by the director of MIME, Professor Jeffrey Rosenfeld AM, OBE, and Leidos Australia technical director Dan Brewer, will focus on the development of innovative technologies and solutions to address human health problems.

"It will foster the development of new technology and IT solutions for human health problems," said Professor Rosenfeld.

"University-industry collaboration is an important goal to create new opportunities for Australian innovation to reach the marketplace."

Brewer added, “Health is a key area for Leidos globally and as we continue to grow domestically, we will be looking to further develop our range of capabilities in this area."

The MoU will also see Leidos Australia and the MIME collaborate on future R&D with the initial contribution including the funding of a PhD research student.

Leidos is one of the primes tendering for Defence's Deployable Health Capability (JP2060 Phase 3), which aims to introduce an entire system (mission system), inclusive of all medical and dental equipment (a turn key solution) and designed to operate as an integrated capability.

The company also signed another MoU with the University of New South Wales to collaborate on research into the development of force protection and biological security for the Australian Defence Force.

 

 

JP2060 Phase 3 contender sets sights on human health research
lawyersweekly logo

more from defence connect

Greg Barsby, QuinetiQ
Feb 21 2019
PODCAST: The shift from consulting business to specialised engineering leader, Greg Barsby, QinetiQ
Greg Barsby, the managing director of QinetiQ Australia, first joined the Defence Connect podcast du...
Feb 22 2019
Lifting the veil on the networked air force with Avalon livestreams
Join a specialist panel to discuss the future of Australian air superiority, the networked force, n...
Feb 22 2019
Defence Innovation Partnership celebrates anniversary
South Australia’s Defence Innovation Partnership is celebrating one year of “driving defence res...
FROM THE WEB
Recommended by Spike Native Network